Next, we investigated the effect of PLA2G4A inhibition on additional MLLr AML lines (Nomo-1 (MLL-AF9) and MV-4-11 (MLL-AF4)) as well as of unrelated AML lines (Kasumi-1 (RUNX1/AML1-RUNX1T1/ETO) and OCI-AML3 (NPM1c)). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.